The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering access to cutting edge trials throughout the US and Europe. Today, with over 1,300 studies completed, and with research facilities in the United States and in Spain, Portugal, and Ireland, START’s mission is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients with cancer and lead to its eventual cure. To date, over 43 therapies conducted at START locations have obtained FDA/EMA approval. Incredibly, while Academic Medical Centers (AMCs) conduct 80% of cancer trials, such trials reach only 20% of the patient population – leaving the majority of patients who are treated in community practices and hospitals without access to a clinical trial when their care journey calls for one. START serves the many – by bringing cancer trials to physicians and their patients in community hospitals and practices when hope is needed most.
START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. As an example, in San Antonio, where START was founded, START treated the first patient ever with Keytruda – the most effective cancer drug in medical history.
Essential Responsibilities
Education & Experience
Physical & Travel Requirements:
Best-in-Class Benefits and Perks
We value our employees’ time and efforts. Our commitment to your success is enhanced by a competitive compensation, depending on experience, and an extensive benefits package including:
More about The START Center for Cancer Research
Deeply rooted in community oncology centers globally, The START Center for Cancer Research provides access to specialized preclinical and early-phase clinical trials of novel anti-cancer agents. START clinical trial sites have conducted more than a thousand early-phase clinical trials, including for 43 therapies that were approved by the FDA. START represents the world’s largest roster of Principal Investigators (PIs) across its eight clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world. Learn more at STARTresearch.com .
...Join a growing team where your work matters! IPCMobile is looking for a reliable, detail-oriented Electronics Assembler to help keep our products customized. This is a stable, full-time role with consistent hours (Mon-Fri, 8am-5pm) and excellent benefits from day one....
Real Estate School Administrator Location Halethorpe, MD : Maryland Real Estate Academy, is more than just a real estate school; we are a dynamic partner in navigating the ever-evolving real estate education landscape across Maryland. Our commitment to excellence, deep...
A leading security and intelligence firm is seeking an OSINT Analyst - MID to support mission-critical projects with significant impacts on national security. This role requires candidates to have a Bachelors degree and at least 8 years of experience in data and trend ...
...The Director of Procurement is responsible for overseeing and managing all non-beverage alcohol purchasing, vendor contracts, and compliance across all restaurant units. This role is critical in ensuring cost efficiency, quality control, and operational standardization...
...Senior Faculty Administrator We are seeking a Senior Faculty Administrator to provide high-level administrative and faculty support in a dynamic academic environment. This role, offering pay up to $35/hour, ensures smooth operations across teaching, research, and events...